Access to Medicare increases cancer detection and reduces mortality rate

Access to Medicare significantly impacts detection of certain cancers and life expectancy following cancer diagnosis, according to a study, ‘Does Medicare Coverage Improve Cancer Detection and Mortality Outcomes?', Journal of Policy Analysis and Management’, from the UW School of Medicine and Public Health published online in the Journal of Policy Analysis and Management.

Better surgical outcomes for colorectal cancer patients in high-volume hospitals

Patients with colorectal cancer have a greater chance of survival if they are operated in hospitals with a high case load because complications that can occur after surgery can be better managed there, according to researchers from the University Hospital of Würzburg in Bavaria, Germany.

RICTOR/mTORC2 pathway could be key molecular target for colon cancer

Researchers at Boston University School of Medicine (BUSM) have found a way to help make chemotherapy more effective in treating colon cancer. They identified a new pathway - RICTOR/mTORC2 - as a biological target for the disease and by targeted inhibition of RICTOR or the mTORC2 pathway could be used as a distinctive therapeutic opportunity with chemotherapy for treating colon cancer.

Virtual Incision secures financing to advance MIRA surgical platform

Virtual Incision, a medical device company pioneering a first-of-its-kind miniaturized surgical robot, has announced it has raised US$20 million in a Series B+ financing to support regulatory and clinical programmes leading to the commercialisation of the company’s MIRA (Miniaturized In Vivo Robotic Assistant) Surgical Robotic Platform. The company is filing for an Investigational Device Exemption (IDE) with the FDA, approval will allow the company to initiate a confirmatory clinical study of the MIRA Surgical Robotic Platform in support of regulatory pathway to approval.